Point-of-Care analysis of the hemostatic system;Point-of-Care analyse des hämostasesystems

LaboratoriumsMedizin

Volumn 26, Issue 1-2, 2002, Pages 68-76

  Spannagl, Michael ^a   Calatzis, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bedside analysis; Coagulation; Hemostasis; Near patient testing; Point of care

Indexed keywords

ARTICLE; BLOOD CLOTTING; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; HEMOSTASIS; HUMAN; LABORATORY TEST; PATIENT MONITORING; THROMBOCYTE FUNCTION;

EID: 18344392851     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2002.010     Document Type: Article

References (46)

1. Near-patient testing devices to monitor oral anticoagulant therapy
2. Oral Anticoagulation Monitoring Study Group: Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience
3. Activated coagulation time of whole blood
4. Heparin detection by the activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays
5. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation
6. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomised cross-over comparison
7. INR self-management following mechanical heart valve replacement
8. Point-of-care (POC) measurement of coagulation after cardiac surgery
9. Hemostasis management by use of Hepcon/HMS: Increased bleeding without increased need for blood transfusion
10. Quantitative determination of hirudin in blood and body fluids
11. PFA-100 system: A new method for assessment of platelet dysfunction
12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
13. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
14. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?
15. A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft
16. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients
17. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass
18. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
19. Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus
20. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban
21. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: Results of the GOLD (AU-Assessing Ultegra) multicenter study
22. In vitro dose response to different GPIIb/IIIa-antagonists: Inter-laboratory comparison of various platelet function tests
23. Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
24. Blutgerinnungstudien mit der thrombelastographie, einem neuen untersuchungsverfahren
25. Thromboelastography: Past, present, and future
26. Thrombelastography
27. Thrombelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer
28. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban
29. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery
30. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery
31. Sonoclot analysis
32. The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders
33. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: Summary of a 1999 symposium
34. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery
35. Monitoring of hemostasis in cardiac surgical patients: Impact of point-of-care testing on blood loss and transfusion outcomes
36. The current status of point-of-care monitoring
37. Methods for monitoring hemostasis during and following cardiac surgery
38. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
39. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients
40. Predictive value of blood clotting tests in cardiac surgical patients
41. Changes in blood coagulation during and following cardiopulmonary bypass: Lack of correlation with clinical bleeding
42. Are coagulation studies necessary before percutaneous nephrostomy?
43. Abnormal clotting parameters before therapeutic ERCP: Do they predict major bleeding?
44. Routine preoperative testing: A systematic review of the evidence
45. Thromboelastography for the prediction of bleeding after transplant renal biopsy
46. Usefulness of thrombelastography in assessment of trauma patient coagulation